查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930059

连续性肾臟替代疗法 (CRRT) 市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察，2025-2034 年

Continuous Renal Replacement Therapy Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 请询问到货日

价格

连续性肾臟替代疗法 (CRRT) 市场成长驱动因子

预计 2025 年全球连续性肾臟替代疗法市场规模将达到 12.5 亿美元，2026 年将达到 13.4 亿美元。预计到 2034 年，该市场规模将最终成长至 25.2 亿美元，预测期内复合年增长率 (CAGR) 为 8.20%。北美地区在 2025 年将以 39.72% 的市占率领先，这主要归功于急性肾损伤 (AKI) 盛行率的上升、先进的医疗基础设施以及 CRRT 在重症监护室 (ICU) 的广泛应用。主要参与者包括百特（Baxter）、费森尤斯医疗股份公司（Fresenius Medical Care AG & Co. KGaA）和贝朗（B. Braun SE），他们致力于技术创新和产品拓展。

连续性肾臟替代疗法（CRRT）是一种专门针对血流动力学不稳定和急性肾损伤重症患者的透析技术。与间歇性血液透析不同，CRRT 每天 24 小时持续运行，逐步清除代谢废物、体液和电解质。这最大限度地减少了血流动力学的突然变化，并能更接近地模拟自然肾功能，因此对于重症监护室（ICU）中多重器官衰竭的患者尤其有效。

市场驱动因素

重症监护室（ICU）入院人数增加和急性肾损伤（AKI）盛行率上升：AKI 的发生率在全球范围内不断上升，尤其是在重症患者中。例如，英国肾臟登记处报告称，2023 年急性肾损伤 (AKI) 病例数为 683,136 例，比 2022 年增长 15.8%。慢性疾病、败血症和 COVID-19 併发症导致的重症监护室 (ICU) 入院人数增加，进一步推动了对连续性肾臟替代疗法 (CRRT) 的需求，CRRT 可在维持血流动力学稳定的同时提供持续的肾臟支持。

技术进步：CRRT 系统正在不断发展，自动化程度更高，液体管理更加精细，并整合了人工智慧 (AI) 以进行即时患者监测。 2021 年 5 月，百特公司推出了 PrisMax2，可提供更完善的器官支援和液体管理。这些技术创新正在推动市场成长。

儿科 CRRT 设备：儿科重症监护室患者急性肾损伤 (AKI) 发病率的增加创造了新的成长机会。儿科专用 CRRT 系统能够根据特定的生理需求进行个人化治疗，而不是简单地从成人数据推断。监管机构的批准，例如美国食品药物管理局 (FDA) 于 2024 年 9 月将儿科 CRRT 设备列为 II 类医疗器械，正在促进其安全实施。

市场限制因子

高昂成本：CRRT 系统和耗材的高昂初始成本（估计每天 870 美元，而间歇性血液透析为 270 美元）限制了其在对成本敏感的医疗机构（尤其是在发展中地区）的普及。缺乏熟练的专业人员以及 CRRT 设置的复杂性进一步阻碍了其广泛应用。

市场机会

将人工智慧与家庭 CRRT 解决方案结合：近期的一些拨款和研究计划，例如美国于 2023 年 6 月提供的 380 万美元人工智慧拨款，旨在优化 CRRT 的疗效。便携式家庭 CRRT 解决方案的出现，将市场潜力扩展到医院重症监护室 (ICU) 之外。

市场区隔

依产品类型划分：耗材细分市场将在2026年占领先地位，市占率达73.34%，主要得益于过滤器、透析液、导管和置换液的重复使用。系统细分市场预计将稳定成长，这得益于已开发国家对先进 CRRT 设备的广泛应用。

按疗法划分：连续性静脉-静脉血液透析滤过 (CVVHDF) 透过扩散和对流有效清除溶质，预计将在 2026 年占市场主导地位，市场占有率达 45.55%。其他疗法（CVVHD、CVVH、SCUF 等）预计将随着其临床应用范围的扩大而逐步成长。

依地区划分

  • 北美：受急性肾损伤 (AKI) 高发生率、重症监护室 (ICU) 基础设施建设以及先进 CRRT 系统应用等因素的推动，北美市场预计将占主导地位，2025 年市场规模将达到 4.2 亿美元，2026 年将达到 4.5 亿美元。预计到 2026 年，美国市场规模将达到 4.9 亿美元。
  • 欧洲：受肾臟疾病发病率上升和政府对肾臟护理的重视推动，英国和德国预计将成为第二大市场，到2026年分别达到7000万美元和1亿美元。 亚太地区：成长最快的地区。受人口老化和重症监护室（ICU）急性肾损伤（AKI）高发生率的推动，预计到2026年，日本将达到6,000万美元，中国将达到8,000万美元，印度将达到3,000万美元。 拉丁美洲、中东和非洲：预计成长适中。重症监护室患者中连续性肾臟替代疗法（CRRT）的日益普及以及与全球公司的策略合作将推动成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家急性肾衰竭流行病学（2025 年）
  • 主要国家和地区的健保报销情况
  • 主要公司新产品发布
  • 关键产业趋势：併购与合作
  • 新冠疫情对市场的影响

第五章：全球连续性肾臟替代疗法 (CRRT) 市场分析、洞察与预测 (2021-2034)

  • 市场分析、洞察与预测 - 按产品类型划分
    • 系统
    • 耗材
      • 透析液
      • 置换液
      • 过滤器（血液滤过器、血浆滤过器、其他）
      • 导管
      • 其他
  • 市场分析、洞察与预测 - 按疗法划分
    • 慢速连续超滤 (SCUF)
    • 连续性静脉-静脉血液滤过 (CVVH)
    • 连续性静脉-静脉血液透析 (CVVHD)
    • 连续性静脉-静脉血液透析滤过 (CVVHDF)
  • 市场分析、洞察、及预测 - 按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美连续性肾臟替代疗法 (CRRT) 市场分析、洞察与预测 (2021-2034)

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲连续性肾臟替代疗法 (CRRT) 市场分析、洞察与预测 (2021-2034)

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚半岛
    • 其他地区欧洲

第八章 亚太地区连续性肾臟替代疗法 (CRRT) 市场分析、洞察与预测 (2021-2034)

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲连续性肾臟替代疗法 (CRRT) 市场分析、洞察与预测 (2021-2034)

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章 中东和非洲连续性肾臟替代疗法 (CRRT) 市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 南非
    • 海湾合作委员会
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • 百特
    • 贝朗集团
    • 费森尤斯医疗股公司
    • 旭化成医疗株式会社（旭化成株式会社）
    • 尼普洛株式会社
    • 东丽医疗株式会社（东丽工业株式会社）
    • 日机装株式会社
    • 美敦力
Product Code: FBI102547

Growth Factors of Continuous Renal Replacement Therapy (CRRT) Market

The global Continuous Renal Replacement Therapy (CRRT) market was valued at USD 1.25 billion in 2025 and is projected to reach USD 1.34 billion in 2026, ultimately expanding to USD 2.52 billion by 2034, exhibiting a CAGR of 8.20% during the forecast period. North America dominated the market in 2025 with a 39.72% share, driven by the rising prevalence of acute kidney injury (AKI), advanced healthcare infrastructure, and growing adoption of CRRT in intensive care units (ICUs). Key players include Baxter, Fresenius Medical Care AG & Co. KGaA, and B Braun SE, focusing on technological innovation and product expansion.

CRRT is a specialized form of dialysis designed for critically ill patients with hemodynamic instability and acute kidney injury. Unlike intermittent hemodialysis, CRRT operates continuously over 24 hours, allowing gradual removal of waste, fluids, and electrolytes. This minimizes rapid hemodynamic changes and closely mimics natural kidney function, making it particularly effective for patients with multiple organ failure in ICU settings.

Market Drivers

Increasing ICU Admissions and AKI Prevalence: Globally, the incidence of AKI is rising, particularly among critically ill patients. For instance, the UK Renal Registry reported 683,136 AKI cases in 2023, a 15.8% increase over 2022. Rising ICU admissions due to chronic conditions, sepsis, and COVID-19 complications have further boosted the demand for CRRT, as it provides continuous renal support while maintaining hemodynamic stability.

Technological Advancements: CRRT systems have evolved with enhanced automation, fluid management, and integration of artificial intelligence (AI) for real-time patient monitoring. In May 2021, Baxter launched PrisMax2, offering improved organ support and fluid management, demonstrating how innovation drives market growth.

Pediatric CRRT Devices: The increasing incidence of AKI among pediatric ICU patients presents a new growth opportunity. Specialized CRRT systems for children address unique physiological needs, allowing tailored treatment rather than relying on adult extrapolation. Regulatory approvals, such as the FDA classifying pediatric CRRT devices as Class II in September 2024, facilitate safer adoption.

Market Restraints

High Costs: The high upfront costs of CRRT systems and consumables, estimated at USD 870 per day compared to USD 270 for intermittent hemodialysis, limit adoption in cost-sensitive healthcare settings, particularly in developing regions. Shortage of skilled professionals and the complexity of CRRT setup further restrict widespread implementation.

Market Opportunities

Integration of AI and Home-Based CRRT Solutions: Recent grants and research initiatives, such as the USD 3.8 million U.S. AI grant in June 2023, aim to optimize CRRT outcomes. Portable and home-based CRRT solutions are emerging, expanding market potential beyond hospital ICUs.

Market Segmentation

By Product Type: In 2026, the consumables segment dominated with 73.34% share, driven by repetitive use of filters, dialysates, catheters, and replacement solutions. The systems segment is projected to grow steadily, supported by advanced CRRT devices in developed countries.

By Modality: Continuous Venovenous Hemodiafiltration (CVVHDF) led in 2026 with 45.55% share, due to its effective solute clearance through diffusion and convection. Other modalities, including CVVHD, CVVH, and SCUF, are expected to grow gradually with increasing clinical adoption.

By Region:

  • North America: Dominated with USD 0.42 billion in 2025 and USD 0.45 billion in 2026, driven by high AKI prevalence, ICU infrastructure, and adoption of advanced CRRT systems. The U.S. is projected to reach USD 0.49 billion by 2026.
  • Europe: Second-largest market with projected USD 0.07 billion (UK) and USD 0.1 billion (Germany) in 2026, supported by rising renal disorders and government focus on renal care.
  • Asia Pacific: Fastest-growing region; Japan USD 0.06 billion, China USD 0.08 billion, India USD 0.03 billion in 2026, due to aging populations and high ICU AKI incidence.
  • Latin America & Middle East & Africa: Moderate growth fueled by increasing adoption of CRRT in ICU patients and strategic partnerships with global players.

Competitive Landscape

The market is consolidated, with Baxter, Fresenius Medical Care AG & Co. KGaA, and B Braun SE holding substantial shares. Innovations such as B. Braun's acquisition of Intermedt Medizin & Technik GmbH in March 2022 and Baxter's strategic spin-offs demonstrate the focus on expanding CRRT offerings.

Conclusion

The global CRRT market is projected to expand steadily from USD 1.25 billion in 2025 to USD 2.52 billion by 2034, driven by increasing AKI prevalence, rising ICU admissions, technological innovations, and expanding pediatric and home-based CRRT solutions. North America continues to dominate, while Asia Pacific offers the fastest growth. Consumables and CVVHDF modalities lead the market. Strategic product development and adoption of AI-integrated and user-friendly CRRT systems will further enhance patient outcomes and global market expansion.

Segmentation By Product Type

  • Systems
  • Consumables
    • Dialysates
    • Replacement Solutions
    • Filters
    • Catheters
    • Others

By Modality

  • Slow Continuous Ultra Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

By Region

  • North America (By Product Type, By Modality, By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Modality, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Modality, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Modality, By Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Modality, By Country/Sub-Region)
    • South Africa
    • GCC
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Epidemiology of Acute Kidney Failure by Key Countries, 2025
  • 4.2. Reimbursement Scenario for Key Countries/Regions
  • 4.3. New Product Launches, Key Players
  • 4.4. Key Industry Developments Mergers, Acquisitions, and Partnerships
  • 4.5. Impact of Covid-19 on the Market

5. Global Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Systems
    • 5.1.2. Consumables
      • 5.1.2.1. Dialysates
      • 5.1.2.2. Replacement Solutions
      • 5.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 5.1.2.4. Catheters
      • 5.1.2.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Modality
    • 5.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 5.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 5.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Systems
    • 6.1.2. Consumables
      • 6.1.2.1. Dialysates
      • 6.1.2.2. Replacement Solutions
      • 6.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 6.1.2.4. Catheters
      • 6.1.2.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Modality
    • 6.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 6.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 6.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 6.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Systems
    • 7.1.2. Consumables
      • 7.1.2.1. Dialysates
      • 7.1.2.2. Replacement Solutions
      • 7.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 7.1.2.4. Catheters
      • 7.1.2.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Modality
    • 7.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 7.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 7.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 7.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 7.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia Pacific Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Systems
    • 8.1.2. Consumables
      • 8.1.2.1. Dialysates
      • 8.1.2.2. Replacement Solutions
      • 8.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 8.1.2.4. Catheters
      • 8.1.2.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Modality
    • 8.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 8.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 8.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 8.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 8.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Systems
    • 9.1.2. Consumables
      • 9.1.2.1. Dialysates
      • 9.1.2.2. Replacement Solutions
      • 9.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 9.1.2.4. Catheters
      • 9.1.2.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Modality
    • 9.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 9.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 9.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 9.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 9.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Continuous Renal Replacement Therapy Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Systems
    • 10.1.2. Consumables
      • 10.1.2.1. Dialysates
      • 10.1.2.2. Replacement Solutions
      • 10.1.2.3. Filters (Hemofilters, Plasmafilters, etc.)
      • 10.1.2.4. Catheters
      • 10.1.2.5. Others
  • 10.2. Market Analysis, Insights and Forecast - By Modality
    • 10.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 10.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 10.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 10.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 10.3. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.3.1. South Africa
    • 10.3.2. GCC
    • 10.3.3. Rest of Middle East Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Baxter
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. B. Braun SE
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Fresenius Medical Care AG & Co. KGaA
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. NIPRO Corporation
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Toray Medical Co., Ltd (TORAY INDUSTRIES, INC.)
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Nikkiso Co., Ltd.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Medtronic
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 02: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 03: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 04: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Region, 2021-2034
  • Table 05: North America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 06: North America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 07: North America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 08: North America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 09: Europe Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 10: Europe Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables 2021-2034
  • Table 11: Europe Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 12: Europe Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 14: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 15: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 16: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Latin America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 18: Latin America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 19: Latin America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 20: Latin America Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Product Type, 2021-2034
  • Table 22: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Consumables, 2021-2034
  • Table 23: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, by Modality, 2021-2034
  • Table 24: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Continuous Renal Replacement Therapy (CRRT) Market Revenue Breakdown (USD Billion, %) by Region, 2025 & 2034
  • Figure 02: Global Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 03: Global Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025 & 2034
  • Figure 04: Global Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Region, 2025 & 2034
  • Figure 05: North America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 06: North America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product, 2025
  • Figure 07: North America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 08: North America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 09: North America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country, 2025 & 2034
  • Figure 10: North America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country, 2025
  • Figure 11: Europe Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 12: Europe Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025
  • Figure 13: Europe Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 14: Europe Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 15: Europe Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 17: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 18: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025
  • Figure 19: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 20: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 21: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 23: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 24: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025
  • Figure 25: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 26: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 27: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 29: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 30: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Product Type, 2025
  • Figure 31: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), by Modality, 2025 & 2034
  • Figure 32: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), by Modality, 2025
  • Figure 33: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East and Africa Continuous Renal Replacement Therapy (CRRT) Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 35: Global Continuous Renal Replacement Therapy (CRRT) Market Share (%), By Company, 2025